Table 3. Drug doses received and drug delivered dose intensity (dDDI).
ECMF
|
CMF
|
|||
---|---|---|---|---|
Drugs | % dose received | Median (IQR) dose intensity | % dose received | Median (IQR) dose intensity |
Epirubicin | 99 | 100 (95–105) | 100a | 99 (99–100) |
Oral Cyclophosphamide | 89 | 88 (78–105) | 88 | 87 (77–104) |
i.v. Cyclophosphamide | 96 | 100 (93–104) | 96 | 100 (92–104) |
Methotrexate | 97 | 99 (92–104) | 97 | 99 (91–104) |
5-FU | 97 | 99 (93–104) | 97 | 99 (91–104) |
Based on two CMF patients who received Epirubicin through protocol violations.